Pharmacokinetic and pharmacodynamic effects of small doses of norethisterone released from vaginal rings continuously during 90 days
- 1 March 1979
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 19 (3), 253-271
- https://doi.org/10.1016/0010-7824(79)90020-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Clinical performances and endocrine profiles with contraceptive vaginal rings containing d-norgestrelContraception, 1977
- Pharmacokinetic observations on medroxyprogesterone acetate administered orally and intravaginallyContraception, 1976
- The medroxyprogfstepone acetate intravaginal silasttc ring as a contraceptive deviceContraception, 1976
- Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administrationContraception, 1975
- Peripheral plasma levels of d-norgestrel in women after oral administration of d-norgestrel and when using intravaginal rings impregnated with dl-norgestrelContraception, 1975
- Initial clinical studies of intravaginal rings containing norethindrone and norgestrelContraception, 1975
- Radioimmunoassay of serum medroxyprogesterone acetate (Provera ®) in women following oral and intravaginal administrationSteroids, 1975
- Inhibition of ovulation with cyclic use of progestogen-impregnated intravaginal devicesAmerican Journal of Obstetrics and Gynecology, 1972
- Contraception by means of a Silastic vaginal ring impregnated with medroxyprogesterone acetateAmerican Journal of Obstetrics and Gynecology, 1970
- Contraceptive Effect of Varying Dosages of Progestogen in Silastic Vaginal RingsFertility and Sterility, 1970